(Q34978167)

5 August 2017

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial (English)

1 reference

5 August 2017

0 references

diabetic polyneuropathy

1 reference

Allan H Ropper

1

1 reference

5 August 2017

Kenneth C Gorson

2

1 reference

5 August 2017

Clifton L Gooch

3

1 reference

5 August 2017

David H Weinberg

4

1 reference

5 August 2017

Ann Pieczek

5

1 reference

5 August 2017

James H Ware

6

1 reference

5 August 2017

Joshua Kershen

7

1 reference

5 August 2017

Adam Rogers

8

1 reference

5 August 2017

Drasko Simovic

9

1 reference

5 August 2017

Peter Schratzberger

10

1 reference

5 August 2017

Rudolf Kirchmair

11

1 reference

5 August 2017

Douglas Losordo

12

1 reference

5 August 2017

1 April 2009

1 reference

5 August 2017

1 reference

5 August 2017

65

1 reference

5 August 2017

386-393

1 reference

5 August 2017

4

1 reference

Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Reversal of experimental diabetic neuropathy by VEGF gene transfer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene ex

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FANA.21675

VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4709012

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

26 October 2018

1 reference

12 December 2020

Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities

1 reference

12 December 2020

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

12 December 2020

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

12 December 2020

Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy

1 reference

12 December 2020

Time course of recombinant protein secretion after liposome-mediated gene transfer in a rabbit arterial organ culture model

1 reference

12 December 2020

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

1 reference

12 December 2020

Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA

1 reference

12 December 2020

Identifiers

DOI

10.1002/ANA.21675

1 reference

5 August 2017

1 reference

5 August 2017

1 reference